Retrophin


Retrophin is a biopharmaceutical company developing products including fosmetpantotenate for pantothenate kinase-associated neurodegeneration (PKAN) and sparsentan for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN).

Industries

Employees

1-10

Links


Org chart

Eric Dube
President and Chief Executive Officer
Collapse
Elizabeth Reed
General Counsel and Corporate Secretary
Laura M. Clague
Chief Financial Officer
Noah L. Rosenberg
Chief Medical Officer
Peter Heerma
Chief Commercial Officer
William Rote
SVP, Research and Development


Offices